Surveillance for poliovirus vaccine adverse events, 1991 to 1998: impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine

Pediatrics
W A WattigneyR T Chen

Abstract

The elimination of wild-virus-associated poliomyelitis in the Western Hemisphere in 1991 and rapid progress in global polio eradication efforts changed the risk-benefit ratio associated with the exclusive use of oral poliovirus vaccine (OPV) for routine immunization. These changes, plus the November 1987 development of an enhanced-potency inactivated poliovirus vaccine (IPV), which poses no risk of vaccine-associated paralytic poliomyelitis (VAPP), resulted in a change in polio immunization policy in the United States. In September 1996, the Centers for Disease Control and Prevention recommended that IPV replace OPV for the first 2 doses in a sequential poliovirus vaccine schedule. The Vaccine Adverse Event Reporting System (VAERS), a passive surveillance system for adverse events after receipt of any US-licensed vaccine, is used to monitor postlicensure vaccine safety. Postlicensure surveillance of vaccines is important to identify new, rare, or delayed-onset adverse reactions not detected in prelicensure clinical trials or when new vaccine schedules are adopted. Through continual monitoring of adverse events and identification of potential vaccine risks, VAERS can serve as an important resource to ensure continued public acce...Continue Reading

Citations

Jan 28, 2012·BMC Infectious Diseases·Claudia ReinheimerHans W Doerr
Oct 16, 2014·The Journal of Infectious Diseases·Lauren R PlattRoland W Sutter
Aug 7, 2003·Expert Review of Vaccines·Robert Ball
Apr 28, 2009·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Chia-Yu ChiIh-Jen Su
Apr 20, 2004·The Journal of Emergency Medicine·Hüseyin CaksenRefah Sayin
Nov 29, 2014·Reviews in Medical Virology·Kristen M DrescherSteven Tracy
Jul 22, 2014·Parkinsonism & Related Disorders·Hatice KumruJoan Santamaria
Feb 19, 2013·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Hatice KumruJosep Valls-Sole
Jun 9, 2016·Expert Review of Vaccines·Ian J Amanna, Mark K Slifka
Jul 27, 2004·Arquivos de neuro-psiquiatria·Elza Dias-Tosta, Carlos Santos Kückelhaus
Dec 5, 2019·The Cochrane Database of Systematic Reviews·Agustín CiapponiAikant Bhatti
Jul 10, 2021·British Journal of Clinical Pharmacology·Jun GaoFenyang Tang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Anaphylaxis

Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death.

Related Papers

Zentralblatt Für Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology
K OexleW Gerok
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
N GuérinO Raynaud
American Journal of Public Health and the Nation's Health
Clinical Trials : Journal of the Society for Clinical Trials
Donald S Burke
© 2021 Meta ULC. All rights reserved